These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7747153)

  • 1. Role of agglomeration in the early stages of papillar stone formation.
    Söhnel O; Grases F; Garcia-Ferragut L
    Scanning Microsc; 1994; 8(3):513-21; discussion 521-2. PubMed ID: 7747153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization and stone formation inside the nephron.
    Kok DJ
    Scanning Microsc; 1996; 10(2):471-84; discussion 484-6. PubMed ID: 9813625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP; Bouche R; Boistelle R
    Nephrologie; 1995; 16(4):325-31. PubMed ID: 7630471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation.
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; van 't Noordende JM; Schrder FH
    Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
    Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
    Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does bovine serum albumin prevent the formation of kidney stone? A kinetics study.
    Liu J; Jiang H; Liu XY
    J Phys Chem B; 2006 May; 110(18):9085-9. PubMed ID: 16671718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of crystal surface adhesion in kidney stone disease.
    Wesson JA; Ward MD
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):386-93. PubMed ID: 16775453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney models of calcium oxalate stone formation.
    Robertson WG
    Nephron Physiol; 2004; 98(2):p21-30. PubMed ID: 15499211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.